Production (Stage)
Zealand Pharma A/S
ZLDPF
$62.36
$0.01560.03%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 8.01M | 9.07M | 11.13M | 53.63M | 50.23M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 8.01M | 9.07M | 11.13M | 53.63M | 50.23M |
| Cost of Revenue | 509.10K | 1.12M | 2.76M | 4.49M | 2.36M |
| Gross Profit | 7.50M | 7.95M | 8.37M | 49.14M | 47.87M |
| SG&A Expenses | 62.00M | 58.47M | 45.66M | 39.09M | 35.53M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 3.06M | 14.00K | 470.00K | -214.10K | -214.10K |
| Total Operating Expenses | 212.15M | 193.04M | 173.50M | 157.90M | 144.42M |
| Operating Income | -204.14M | -183.98M | -162.37M | -104.27M | -94.19M |
| Income Before Tax | -171.06M | -157.05M | -153.68M | -103.59M | -108.06M |
| Income Tax Expenses | -668.60K | -671.40K | -671.70K | -661.40K | -697.70K |
| Earnings from Continuing Operations | -170.39 | -156.38 | -153.01 | -102.93 | -107.37 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -170.39M | -156.38M | -153.01M | -102.93M | -107.37M |
| EBIT | -204.14M | -183.98M | -162.37M | -104.27M | -94.19M |
| EBITDA | -201.04M | -180.75M | -159.28M | -101.48M | -90.51M |
| EPS Basic | -2.49 | -2.36 | -2.42 | -1.68 | -1.81 |
| Normalized Basic EPS | -1.64 | -1.55 | -1.56 | -1.07 | -0.93 |
| EPS Diluted | -2.49 | -2.36 | -2.42 | -1.69 | -1.82 |
| Normalized Diluted EPS | -1.64 | -1.55 | -1.56 | -1.07 | -0.93 |
| Average Basic Shares Outstanding | 274.69M | 265.72M | 253.35M | 241.07M | 236.48M |
| Average Diluted Shares Outstanding | 274.69M | 265.72M | 253.35M | 242.97M | 238.38M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |